Target intelligence / Profile preview

Apoptosis signal-regulating kinase 1 (ASK1) (ASK1)

Target
ASK1
Molecular classification
Enzyme, Kinase, Serine/threonine-protein kinase, MAP kinase kinase kinase
01

Overview

Apoptosis signal-regulating kinase 1 (ASK1), also known as MAP3K5, is a key serine/threonine kinase that mediates "Reactive oxygen species–sensitive apoptosis signaling" (UniProt: Q99683). It functions as a redox-sensitive molecular switch; in its inactive state, ASK1 is bound to the antioxidant protein thioredoxin (Trx). Upon the accumulation of reactive oxygen species (ROS), Trx becomes oxidized and dissociates, allowing ASK1 to autophosphorylate and activate downstream mitogen-activated protein kinases (MAPKs), specifically JNK and p38 (PubMed: 10409703). This signaling cascade is a critical driver of apoptosis, inflammation, and fibrosis in response to cellular stress. Pathological overactivation of the ASK1 pathway is implicated in several chronic conditions, including non-alcoholic steatohepatitis (NASH), diabetic kidney disease, and various neurodegenerative and cardiovascular diseases (PubMed: 28844882). Consequently, ASK1 has been targeted by pharmaceutical developers using small-molecule inhibitors like selonsertib (GS-4997) to prevent cell death and tissue damage. While early clinical trials showed promise in inflammatory and fibrotic diseases, achieving significant clinical endpoints in late-stage trials has proven challenging (ClinicalTrials.gov: NCT02885350).

Other names
MAP3K5Mitogen-activated protein kinase kinase kinase 5MAPKKK5MEKK5Reactive oxygen species–sensitive apoptosis signaling
02

Mechanism of action

Small molecule inhibition of the ASK1 kinase domain to block downstream JNK and p38 MAPK activation.

03

Biological functions

ApoptosisSignal transductionCell deathOxidative stress responseInflammation
04

Disease associations

Non-alcoholic steatohepatitis (NASH)Diabetic kidney diseaseNeurodegenerative diseaseCardiovascular diseaseCancer
05

Safety considerations

Potential for off-target kinase activityInhibition of physiological apoptosisLimited clinical efficacy in Phase 3 trials
06

Interacting drugs

Selonsertib

1 more in the full profile.

07

Biomarkers

Phospho-p38 MAPKPhospho-JNKThioredoxin-1Serum ALT/AST

Beyond the preview

Go deeper on Apoptosis signal-regulating kinase 1 (ASK1) (ASK1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apoptosis signal-regulating kinase 1 (ASK1) (ASK1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call